Location of cAMP-dependent protein kinase type I with the TCR-CD3 complex

Science. 1994 Jan 7;263(5143):84-7. doi: 10.1126/science.8272870.

Abstract

Selective activation of cyclic adenosine 3',5'-monophosphate (cAMP)-dependent protein kinase type I (cAKI), but not type II, is sufficient to mediate inhibition of T cell replication induced through the antigen-specific T cell receptor-CD3 (TCR-CD3) complex. Immunocytochemistry and immunoprecipitation studies of the molecular mechanism by which cAKI inhibits TCR-CD3-dependent T cell replication demonstrated that regulatory subunit I alpha, along with its associated kinase activity, translocated to and interacted with the TCR-CD3 complex during T cell activation and capping. Regulatory subunit II alpha did not. When stimulated by cAMP, the cAKI localized to the TCR-CD3 complex may release kinase activity that, through phosphorylation, might uncouple the TCR-CD3 complex from intracellular signaling systems.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carrier Proteins / analysis
  • Carrier Proteins / metabolism*
  • Cyclic AMP / metabolism
  • Cyclic AMP-Dependent Protein Kinase Type II
  • Cyclic AMP-Dependent Protein Kinases / analysis
  • Cyclic AMP-Dependent Protein Kinases / metabolism*
  • Enzyme Activation
  • Fluorescent Antibody Technique
  • Humans
  • Immunologic Capping
  • Intracellular Signaling Peptides and Proteins*
  • Lymphocyte Activation
  • Phosphorylation
  • Precipitin Tests
  • Receptor-CD3 Complex, Antigen, T-Cell / analysis
  • Receptor-CD3 Complex, Antigen, T-Cell / metabolism*
  • Signal Transduction
  • T-Lymphocytes / enzymology*
  • T-Lymphocytes / immunology

Substances

  • Carrier Proteins
  • Intracellular Signaling Peptides and Proteins
  • Receptor-CD3 Complex, Antigen, T-Cell
  • protein kinase modulator
  • Cyclic AMP
  • Cyclic AMP-Dependent Protein Kinase Type II
  • Cyclic AMP-Dependent Protein Kinases